StockIQpro
NASDAQ:IVVD

Invivyd, Inc.

Invivyd, Inc.'s revenue grew 110.5% in fiscal 2025 to $53.4M while operating margin rose to −104.0%. Free cash flow was −$58.3M, −109.1% of revenue, and the diluted share count rose 45.3%.Summary generated from Invivyd, Inc.'s SEC filings. Latest annual report filed Mar 5, 2026.

Revenue (FY25)$53.4M
Revenue growth+110.5%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−104.0%
Net margin−98.2%
ROICn/a
Return on equity−34.0%
Debt / equityn/a
Free cash flow−$58.3M
FCF margin−109.1%
Share count change+45.3%

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/an/a02553
Operating income−227−248−213−177−56
Net income−227−241−199−170−52
Free cash flow−185−222−174−171−58

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)